Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
8.51
-1.00 (-10.52%)
At close: May 29, 2025, 4:00 PM
8.09
-0.42 (-4.94%)
After-hours: May 29, 2025, 7:55 PM EDT

Rapport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
May '25 Dec '24 Dec '23 Dec '22
Market Capitalization
311649--
Enterprise Value
33330--
Last Close Price
8.5117.74--
Debt / Equity Ratio
0.030.010.050.54
Quick Ratio
30.4234.8216.7518.74
Current Ratio
31.0135.3417.1418.80
Return on Equity (ROE)
-33.14%-35.09%-43.36%-
Return on Assets (ROA)
-22.88%-22.07%-24.18%-
Return on Capital (ROIC)
-23.71%-22.86%-25.52%-
Buyback Yield / Dilution
-1632.08%-1277.25%-93.74%-
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q